HEATHER LAWRENCE: Open Payments
NPI 1851115729 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 44 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| Amgen Inc. | 5 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| PFIZER INC. | 3 | $61 |
| BridgeBio Pharma, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $42 |
Products named: JARDIANCE, LEQVIO, SHINGRIX, REPATHA, LifeVest, Kerendia, FARXIGA, Attruby.
Industry payments across TN — which companies pay providers there.
